GEt Quote
  • Upconverting Nanoparticles - (UCNPs)

    Oct 24, 2017 | ACS MATERIAL LLC

    Upconverting nanoparticles (UCNPs) are among the few materials that can take low-energy, deeply penetrating near-infrared (NIR) light and turn it into higher-energy visible or ultraviolet light. This anti-Stokes behavior—emitting photons of shorter wavelength than the excitation—underpins a fast-growing toolkit for deep-tissue bioimaging, photodynamic therapy, biosensing, anticounterfeiting and photocatalysis.2 This article reviews how UCNPs work, why lanthanide ions and fluoride hosts are central to their performance, and where the field is heading, with interactive simulators to make the underlying photophysics intuitive.

    1.  The anti-Stokes principle: building higher-energy light from lower-energy photons

    Most conventional fluorescence follows a Stokes shift: a fluorophore absorbs one photon and emits a photon of lower energy, with the difference lost mainly as heat. Upconversion does the opposite. A UCNP absorbs two or more low-energy NIR photons in sequence and emits a single photon of higher energy in the visible or UV range.1,4 Because the emitted photon is bluer than the light that went in, the process is described as an anti-Stokes shift.

    The key is that upconversion is not a simple "photon-merging" event. The energy of successive NIR photons is stored in real, long-lived electronic excited states of lanthanide ions and accumulated step by step before being released as one higher-energy photon—although some energy is always lost non-radiatively along the way.1,9 The simulator below contrasts ordinary fluorescence (one photon in, a lower-energy photon out) with upconversion (two NIR photons in, one visible photon out).

    2.  Upconversion mechanisms: ESA, ETU and energy migration

    Several distinct photophysical pathways can produce upconversion luminescence. The three most important are excited-state absorption, energy-transfer upconversion, and energy-migration-mediated upconversion.1,4,17

    Excited-state absorption (ESA) occurs within a single ion that has several long-lived, evenly spaced energy levels. The ion absorbs one photon to reach an intermediate state, then absorbs a second photon to climb to a higher emitting state. ESA dominates when the concentration of optically active ions is low, so that ions are too far apart to exchange energy efficiently.4

    Energy-transfer upconversion (ETU) is the most efficient and widely exploited route. It uses two types of ion: a sensitizer that absorbs the NIR light and an activator that emits. The sensitizer transfers its energy non-radiatively to a neighboring activator, promoting it up a ladder of excited states until it can emit a visible photon.4,9 Yb³⁺ is the classic sensitizer because it has a relatively large absorption cross-section near 980 nm compared with many lanthanide activator ions, and a simple two-level structure that pairs well with activators such as Er³⁺, Tm³⁺ and Ho³⁺.14,3 The simulator below walks through the canonical Yb³⁺ → Er³⁺ ETU cycle step by step.

    Energy-migration-mediated upconversion (EMU) is a more recent addition. In carefully layered core–shell nanostructures, energy hops through a network of intermediary ions (often Gd³⁺) to reach activators that lack the convenient ladder of intermediate states needed for ETU, greatly expanding the palette of emitter ions and colors.17,16

    3.  Host lattices and dopant pairs: why β-NaYF₄:Yb,Er is a workhorse

    Upconversion efficiency depends as much on the host crystal as on the emitter ions. The host must accommodate the lanthanide dopants, hold them at suitable distances, and—critically—have low phonon energy, so that the energy stored in intermediate states is released as light rather than dissipated as lattice vibrations (heat).4,7

    Fluorides excel here. They combine good chemical stability with low maximum phonon energies of roughly 350 cm⁻¹, lower than many oxide hosts, which minimizes non-radiative losses at the intermediate states.7 Among fluorides, hexagonal-phase (β) NaYF₄ is one of the most efficient host lattices known for NIR-to-visible upconversion, and is reported to be several times brighter than its cubic (α) counterpart—by one measure roughly 4.4× for Yb³⁺/Er³⁺ microcrystals.4,7 Precise control of crystal phase and particle size can itself be achieved through lanthanide doping, giving a powerful handle on upconversion output.6

    The choice of activator sets the emission color. Yb³⁺/Er³⁺ gives characteristic green (around 520–540 nm) and red (around 650 nm) bands; Yb³⁺/Tm³⁺ produces blue and NIR emission; and Yb³⁺/Ho³⁺ yields green and red.3,5 One important caveat for quantitative work: the absolute upconversion quantum yield of typical UCNPs remains low—often well under 1% at moderate excitation intensities—which is an active target for improvement through core–shell engineering and dopant optimization.8,10

    4.  Why near-infrared light? The biological optical window

    For biomedical use, the excitation wavelength matters enormously. UV and short-wavelength visible light are strongly scattered and absorbed by tissue, reach only shallow depths, and—particularly in the UV—carry enough photon energy to damage DNA and cells during prolonged exposure. They also excite broad autofluorescence from endogenous biomolecules, which raises background and lowers image contrast.11,17

    NIR light lies within the so-called biological optical windows (roughly 650–950 nm for NIR-I and 1000–1700 nm for NIR-II), where tissue absorption and scattering are relatively low. As a result, NIR penetrates substantially deeper than UV or visible light and, under appropriate irradiation conditions, generally causes less photodamage.11,18,15 The simulator below lets you compare how UV/visible versus NIR excitation propagate into tissue.

    One practical subtlety: the popular 980 nm excitation band overlaps an absorption peak of water, which can cause local heating in tissue. A widely adopted solution is to add Nd³⁺ as a sensitizer and excite at around 808 nm, where water absorption is much lower; the energy then cascades Nd³⁺ → Yb³⁺ → activator within a core–shell architecture, reducing the heating effect while preserving upconversion.14,15

    5.  Applications

    5.1  Deep-tissue bioimaging

    Because UCNPs are excited in the NIR and emit by an anti-Stokes shift, tissue autofluorescence is greatly reduced—there is essentially no competing upconverted background from tissue. Combined with their narrow emission bands (typically tens of nm wide), long luminescence lifetimes and high photostability, this gives UCNPs an exceptionally high signal-to-background ratio for imaging deep in tissue.11,17,4 The simulator below illustrates the contrast difference between a conventional Stokes probe and an NIR-excited UCNP against an autofluorescent tissue background.

    5.2  Photodynamic therapy (PDT)

    In PDT, light activates a photosensitizer that generates cytotoxic reactive oxygen species (ROS) to destroy diseased cells. Many conventional externally illuminated photosensitizers are activated by visible or red light, so light penetration remains a major constraint, especially for deep-seated lesions. UCNPs act as in situ light transducers: delivered to a target site, the nanoparticle absorbs deeply penetrating NIR light and upconverts it into visible or UV emission locally, which then activates a nearby photosensitizer to produce ROS.12,13,18 This extends light-triggered therapy to deeper tissue while potentially improving spatial control and reducing surface photodamage. Selected experimental studies have demonstrated NIR-triggered ROS generation and tumor-cell killing through roughly a centimeter of tissue in animal models using UCNP–photosensitizer constructs.13,12

    5.3  Biosensing, drug delivery and beyond

    The same properties support a broad range of further applications. UCNPs serve as donors in luminescence-resonance-energy-transfer (LRET) biosensors, where binding events modulate the upconverted signal; as NIR-triggered carriers for photoactivated drug release; and as luminescent thermometers that read local temperature from the ratio of Er³⁺ emission bands.16,12,5 Beyond biomedicine, their sharp, NIR-excited emission and difficulty to counterfeit make them attractive for security inks and anticounterfeiting, and their ability to convert sub-bandgap photons has been explored for photocatalysis and solar-energy harvesting.5,17

    6.  Challenges and outlook

    UCNPs are not without limitations. Their absolute quantum yields remain modest, especially for ultrasmall particles where surface quenching is severe; emission can saturate or change with excitation power; and reproducible, scalable synthesis with tight control of size, phase and surface chemistry is demanding.8,10,16 The field is addressing these through epitaxial core–shell and multi-shell designs that shield emitters from surface quenchers, heavy doping strategies that boost brightness, dye-sensitization to broaden and strengthen NIR absorption, and shifting excitation to 808 nm to minimize heating.10,14,8 As these advances mature, UCNPs are well positioned to remain at the forefront of NIR-driven imaging, therapy and sensing.

    ACS Material UCNP Products

    ACS Material supplies a range of surface-functionalized upconverting nanoparticles for research in bioimaging, therapeutics and sensing:

    References

    1. 1. Auzel, F. Upconversion and anti-Stokes processes with f and d ions in solids. Chemical Reviews 2004. https://doi.org/10.1021/cr020357g
    2. 2. Haase, M.; Schäfer, H. Upconverting nanoparticles. Angewandte Chemie International Edition 2011. https://doi.org/10.1002/anie.201005159
    3. 3. Wang, F.; Liu, X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chemical Society Reviews 2009. https://doi.org/10.1039/b809132n
    4. 4. Chen, G.; Qiu, H.; Prasad, P. N.; Chen, X. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chemical Reviews 2014. https://doi.org/10.1021/cr400425h
    5. 5. Zhou, B.; Shi, B.; Jin, D.; Liu, X. Controlling upconversion nanocrystals for emerging applications. Nature Nanotechnology 2015. https://doi.org/10.1038/nnano.2015.251
    6. 6. Wang, F.; Han, Y.; Lim, C. S.; et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010. https://doi.org/10.1038/nature08777
    7. 7. Krämer, K. W.; Biner, D.; Frei, G.; et al. Hexagonal sodium yttrium fluoride based green and blue emitting upconversion phosphors. Chemistry of Materials 2004. https://doi.org/10.1021/cm031124o
    8. 8. Wilhelm, S. Perspectives for upconverting nanoparticles. ACS Nano 2017. https://doi.org/10.1021/acsnano.7b07120
    9. 9. Dong, H.; Sun, L.-D.; Yan, C.-H. Energy transfer in lanthanide upconversion studies for extended optical applications. Chemical Society Reviews 2015. https://doi.org/10.1039/c4cs00188e
    10. 10. Wen, S.; Zhou, J.; Zheng, K.; et al. Advances in highly doped upconversion nanoparticles. Nature Communications 2018. https://doi.org/10.1038/s41467-018-04813-5
    11. 11. Wu, X.; Chen, G.; Shen, J.; et al. Upconversion nanoparticles: a versatile solution to multiscale biological imaging. Bioconjugate Chemistry 2015. https://doi.org/10.1021/acs.bioconjchem.5b00193
    12. 12. Idris, N. M.; Jayakumar, M. K. G.; Bansal, A.; Zhang, Y. Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications. Chemical Society Reviews 2015. https://doi.org/10.1039/c4cs00158c
    13. 13. Wang, C.; Cheng, L.; Liu, Z. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics 2013. https://doi.org/10.7150/thno.5305
    14. 14. Wang, Y.-F.; Liu, G.-Y.; Sun, L.-D.; et al. Nd³⁺-sensitized upconversion nanophosphors: efficient in vivo bioimaging probes with minimized heating effect. ACS Nano 2013. https://doi.org/10.1021/nn403643m
    15. 15. Zhan, Q.; Qian, J.; Liang, H.; et al. Using 915 nm laser excited Tm³⁺/Er³⁺/Ho³⁺-doped NaYbF₄ upconversion nanoparticles for in vitro and deeper in vivo bioimaging without overheating irradiation. ACS Nano 2011. https://doi.org/10.1021/nn200319q
    16. 16. Zhang, J. et al. Recent advances in upconversion nanoparticles for therapeutics: from fundamentals to cutting-edge applications. Electron 2025, 3 (3). https://doi.org/10.1002/elt2.70012
    17. 17. Pliss, A.; et al. Lanthanide-doped upconversion nanoparticles: exploring a treasure trove of NIR-mediated emerging applications. ACS Applied Materials & Interfaces 2023. https://doi.org/10.1021/acsami.2c12370
    18. 18. Xu, D.; Li, C.; Li, W.; Lin, B.; Lv, R. Recent advances in lanthanide-doped up-conversion probes for theranostics. Frontiers in Chemistry 2023. https://doi.org/10.3389/fchem.2023.1036715